Drugs / Tag-7 gene modified inactivated tumor cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04180774 | Jan 2001 → Dec 2018 | kidney cancer, melanoma | N.N. Petrov National Medical Research Center of Oncology | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tag-7 gene modified inactivated tumor cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04180774 ↗ |
| Route | Subcutaneous | “Patients received GMV once in three weeks subcutaneously in three points in the paravertebral region” NCT04180774 ↗ |